Identification of Stage IIIC/IV EGFR-Mutated Non-Small Cell Lung Cancer Populations Sensitive to Targeted Therapy Based on a PET/CT Radiomics Risk Model

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Prognostic nomogram combining 18F-FDG PET/CT radiomics and clinical data for stage III NSCLC survival prediction

Article in Scientific Reports (September 2024)

Exploring the potential of Radiomics in identification and treatment of lung cancer: A systematic evaluation

Article in Multimedia Tools and Applications (December 2023)

Application of PET/CT in the treatment of epidermal growth factor receptor tyrosine kinase inhibitor in patients with advanced non-small cell lung cancer

Article in Chinese Journal of Nuclear Medicine and Molecular Imaging (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.